Cargando…
Long-Term Toxicity of (213)Bi-Labelled BSA in Mice
BACKGROUND: Short-term toxicological evaluations of alpha-radioimmunotherapy have been reported in preclinical assays, particularly using bismuth-213 ((213)Bi). Toxicity is greatly influenced not only by the pharmacokinetics and binding specificity of the vector but also by non-specific irradiation...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794211/ https://www.ncbi.nlm.nih.gov/pubmed/26982495 http://dx.doi.org/10.1371/journal.pone.0151330 |
_version_ | 1782421454880505856 |
---|---|
author | Dorso, Laëtitia Bigot-Corbel, Edith Abadie, Jérôme Diab, Maya Gouard, Sébastien Bruchertseifer, Frank Morgenstern, Alfred Maurel, Catherine Chérel, Michel Davodeau, François |
author_facet | Dorso, Laëtitia Bigot-Corbel, Edith Abadie, Jérôme Diab, Maya Gouard, Sébastien Bruchertseifer, Frank Morgenstern, Alfred Maurel, Catherine Chérel, Michel Davodeau, François |
author_sort | Dorso, Laëtitia |
collection | PubMed |
description | BACKGROUND: Short-term toxicological evaluations of alpha-radioimmunotherapy have been reported in preclinical assays, particularly using bismuth-213 ((213)Bi). Toxicity is greatly influenced not only by the pharmacokinetics and binding specificity of the vector but also by non-specific irradiation due to the circulating radiopharmaceutical in the blood. To assess this, an acute and chronic toxicity study was carried out in mice injected with (213)Bi-labelled Bovine Serum Albumin ((213)Bi-BSA) as an example of a long-term circulating vector. METHOD: Biodistribution of (213)Bi-BSA and (125)I-BSA were compared in order to evaluate (213)Bi uptake by healthy organs. The doses to organs for injected (213)Bi-BSA were calculated. Groups of nude mice were injected with 3.7, 7.4 and 11.1 MBq of (213)Bi-BSA and monitored for 385 days. Plasma parameters, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN) and creatinine, were measured and blood cell counts (white blood cells, platelets and red blood cells) were performed. Mouse organs were examined histologically at different time points. RESULTS: Haematological toxicity was transient and non-limiting for all evaluated injected activities. At the highest injected activity (11.1 MBq), mice died from liver and kidney failure (median survival of 189 days). This liver toxicity was identified by an increase in both ALT and AST and by histological examination. Mice injected with 7.4 MBq of (213)Bi-BSA (median survival of 324 days) had an increase in plasma BUN and creatinine due to impaired kidney function, confirmed by histological examination. Injection of 3.7 MBq of (213)Bi-BSA was safe, with no plasma enzyme modifications or histological abnormalities. CONCLUSION: Haematological toxicity was not limiting in this study. Liver failure was observed at the highest injected activity (11.1 MBq), consistent with liver damage observed in human clinical trials. Intermediate injected activity (7.4 MBq) should be used with caution because of the risk of long-term toxicity to kidneys. |
format | Online Article Text |
id | pubmed-4794211 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-47942112016-03-23 Long-Term Toxicity of (213)Bi-Labelled BSA in Mice Dorso, Laëtitia Bigot-Corbel, Edith Abadie, Jérôme Diab, Maya Gouard, Sébastien Bruchertseifer, Frank Morgenstern, Alfred Maurel, Catherine Chérel, Michel Davodeau, François PLoS One Research Article BACKGROUND: Short-term toxicological evaluations of alpha-radioimmunotherapy have been reported in preclinical assays, particularly using bismuth-213 ((213)Bi). Toxicity is greatly influenced not only by the pharmacokinetics and binding specificity of the vector but also by non-specific irradiation due to the circulating radiopharmaceutical in the blood. To assess this, an acute and chronic toxicity study was carried out in mice injected with (213)Bi-labelled Bovine Serum Albumin ((213)Bi-BSA) as an example of a long-term circulating vector. METHOD: Biodistribution of (213)Bi-BSA and (125)I-BSA were compared in order to evaluate (213)Bi uptake by healthy organs. The doses to organs for injected (213)Bi-BSA were calculated. Groups of nude mice were injected with 3.7, 7.4 and 11.1 MBq of (213)Bi-BSA and monitored for 385 days. Plasma parameters, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN) and creatinine, were measured and blood cell counts (white blood cells, platelets and red blood cells) were performed. Mouse organs were examined histologically at different time points. RESULTS: Haematological toxicity was transient and non-limiting for all evaluated injected activities. At the highest injected activity (11.1 MBq), mice died from liver and kidney failure (median survival of 189 days). This liver toxicity was identified by an increase in both ALT and AST and by histological examination. Mice injected with 7.4 MBq of (213)Bi-BSA (median survival of 324 days) had an increase in plasma BUN and creatinine due to impaired kidney function, confirmed by histological examination. Injection of 3.7 MBq of (213)Bi-BSA was safe, with no plasma enzyme modifications or histological abnormalities. CONCLUSION: Haematological toxicity was not limiting in this study. Liver failure was observed at the highest injected activity (11.1 MBq), consistent with liver damage observed in human clinical trials. Intermediate injected activity (7.4 MBq) should be used with caution because of the risk of long-term toxicity to kidneys. Public Library of Science 2016-03-16 /pmc/articles/PMC4794211/ /pubmed/26982495 http://dx.doi.org/10.1371/journal.pone.0151330 Text en © 2016 Dorso et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Dorso, Laëtitia Bigot-Corbel, Edith Abadie, Jérôme Diab, Maya Gouard, Sébastien Bruchertseifer, Frank Morgenstern, Alfred Maurel, Catherine Chérel, Michel Davodeau, François Long-Term Toxicity of (213)Bi-Labelled BSA in Mice |
title | Long-Term Toxicity of (213)Bi-Labelled BSA in Mice |
title_full | Long-Term Toxicity of (213)Bi-Labelled BSA in Mice |
title_fullStr | Long-Term Toxicity of (213)Bi-Labelled BSA in Mice |
title_full_unstemmed | Long-Term Toxicity of (213)Bi-Labelled BSA in Mice |
title_short | Long-Term Toxicity of (213)Bi-Labelled BSA in Mice |
title_sort | long-term toxicity of (213)bi-labelled bsa in mice |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794211/ https://www.ncbi.nlm.nih.gov/pubmed/26982495 http://dx.doi.org/10.1371/journal.pone.0151330 |
work_keys_str_mv | AT dorsolaetitia longtermtoxicityof213bilabelledbsainmice AT bigotcorbeledith longtermtoxicityof213bilabelledbsainmice AT abadiejerome longtermtoxicityof213bilabelledbsainmice AT diabmaya longtermtoxicityof213bilabelledbsainmice AT gouardsebastien longtermtoxicityof213bilabelledbsainmice AT bruchertseiferfrank longtermtoxicityof213bilabelledbsainmice AT morgensternalfred longtermtoxicityof213bilabelledbsainmice AT maurelcatherine longtermtoxicityof213bilabelledbsainmice AT cherelmichel longtermtoxicityof213bilabelledbsainmice AT davodeaufrancois longtermtoxicityof213bilabelledbsainmice |